Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
79 "Epithelial"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Review
Article image
Cervical intraepithelial neoplasia and cervical cytology in pregnancy
Ji-Young Kim, Jeong Yun Shim
J Pathol Transl Med. 2024;58(6):283-290.   Published online November 7, 2024
DOI: https://doi.org/10.4132/jptm.2024.10.17
  • 2,219 View
  • 268 Download
AbstractAbstract PDF
Cervical cancer screening during pregnancy presents unique challenges for cytologic interpretation. This review focuses on pregnancy-associated cytomorphological changes and their impact on diagnosis of cervical intraepithelial neoplasia (CIN) and cervical cancer. Pregnancy-induced alterations include navicular cells, hyperplastic endocervical cells, immature metaplastic cells, and occasional decidual cells or trophoblasts. These changes can mimic abnormalities such as koilocytosis, adenocarcinoma in situ, and high-grade squamous intraepithelial lesions, potentially leading to misdiagnosis. Careful attention to nuclear features and awareness of pregnancy-related changes are crucial for correct interpretation. The natural history of CIN during pregnancy shows higher regression rates, particularly for CIN 2, with minimal risk of progression. Management of abnormal cytology follows modified risk-based guidelines to avoid invasive procedures, with treatment typically deferred until postpartum. The findings reported in this review emphasize the importance of considering pregnancy status in cytological interpretation, highlight potential problems, and provide guidance on differentiating benign pregnancy-related changes from true abnormalities. Understanding these nuances is essential for accurate diagnosis and proper management of cervical abnormalities in pregnant women.
Case Study
Article image
EWSR1 rearranged primary renal myoepithelial carcinoma: a diagnostic conundrum
Nilay Nishith, Zachariah Chowdhury
J Pathol Transl Med. 2023;57(5):284-288.   Published online September 15, 2023
DOI: https://doi.org/10.4132/jptm.2023.08.08
  • 2,205 View
  • 201 Download
AbstractAbstract PDF
Primary renal myoepithelial carcinoma is an exceedingly rare neoplasm with an aggressive phenotype and Ewing sarcoma breakpoint region 1 (EWSR1) rearrangement in a small fraction of cases. In addition to its rarity, the diagnosis can be challenging for the pathologist due to morphologic heterogeneity, particularly on the biopsy specimen. At times, immunohistochemistry may be indecisive; therefore, molecular studies should be undertaken for clinching the diagnosis. We aim to illustrate a case of primary myoepithelial carcinoma of the kidney with EWSR1-rearrangement in a 67-year-old male patient who presented with right supraclavicular mass, which was clinically diagnosed as carcinoma of an unknown primary. An elaborate immunohistochemical work-up aided by fluorescent in-situ hybridization allowed us to reach a conclusive diagnosis. This unusual case report advocates that one should be aware of the histological mimickers and begin with broad differential diagnoses alongside sporadic ones and then narrow them down with appropriate ancillary studies.
Review
Article image
Trouble-makers in cytologic interpretation of the uterine cervix
Eunah Shin, Jaeeun Yu, Soon Won Hong
J Pathol Transl Med. 2023;57(3):139-146.   Published online May 15, 2023
DOI: https://doi.org/10.4132/jptm.2023.04.25
  • 5,276 View
  • 391 Download
  • 3 Web of Science
  • 3 Crossref
AbstractAbstract PDF
The development and standardization of cytologic screening of the uterine cervix has dramatically decreased the prevalence of squamous cell carcinoma of the uterine cervix. Advances in the understanding of biology of human papillomavirus have contributed to upgrading the histologic diagnosis of the uterine cervix; however, cytologic screening that should triage those that need further management still poses several difficulties in interpretation. Cytologic features of high grade intraepithelial squamous lesion (HSIL) mimics including atrophy, immature metaplasia, and transitional metaplasia, and glandular lesion masquerades including tubal metaplasia and HSIL with glandular involvement are described with accentuation mainly on the differential points. When the cytologic features lie in a gray zone between the differentials, the most important key to the more accurate interpretation is sticking to the very basics of cytology; screening the background and cellular architecture, and then scrutinizing the nuclear and cytoplasmic details.

Citations

Citations to this article as recorded by  
  • Risk of cervical stenosis after cervical excision in postmenopausal patients
    Eva Hauge, Line Winther Gustafson, Mette Tranberg, Pinar Bor
    European Journal of Obstetrics & Gynecology and Reproductive Biology.2025; 308: 208.     CrossRef
  • Pitfalls in Gynecological Cytology: Review of the Common and Less Frequent Entities in Pap Test
    Danijela Vrdoljak-Mozetič, Snježana Štemberger-Papić, Damjana Verša Ostojić, Roberta Rubeša, Marko Klarić, Senija Eminović
    Acta Cytologica.2024; 68(3): 281.     CrossRef
  • Cytological features of human papillomavirus‐infected immature squamous metaplastic cells from cervical intraepithelial neoplasia grade 2
    Mitsuaki Okodo, Kaori Okayama, Koji Teruya, Ruku Shinohara, Shuichi Mizuno, Rei Settsu, Yasuyoshi Ishii, Masahiko Fujii, Hirokazu Kimura, Mizue Oda
    Journal of Medical Virology.2023;[Epub]     CrossRef
Original Articles
Article image
Diagnostic distribution and pitfalls of glandular abnormalities in cervical cytology: a 25-year single-center study
Jung-A Sung, Ilias P. Nikas, Haeryoung Kim, Han Suk Ryu, Cheol Lee
J Pathol Transl Med. 2022;56(6):354-360.   Published online November 9, 2022
DOI: https://doi.org/10.4132/jptm.2022.09.05
  • 4,530 View
  • 125 Download
  • 3 Web of Science
  • 1 Crossref
AbstractAbstract PDF
Background
Detection of glandular abnormalities in Papanicolaou (Pap) tests is challenging. This study aimed to review our institute’s experience interpreting such abnormalities, assess cytohistologic concordance, and identify cytomorphologic features associated with malignancy in follow-up histology.
Methods
Patients with cytologically-detected glandular lesions identified in our pathology records from 1995 to 2020 were included in this study.
Results
Of the 683,197 Pap tests performed, 985 (0.144%) exhibited glandular abnormalities, 657 of which had tissue follow-up available. One hundred eighty-eight cases were cytologically interpreted as adenocarcinoma and histologically diagnosed as malignant tumors of various origins. There were 213 cases reported as atypical glandular cells (AGC) and nine cases as adenocarcinoma in cytology, yet they were found to be benign in follow-up histology. In addition, 48 cases diagnosed with AGC and six with adenocarcinoma cytology were found to have cervical squamous lesions in follow-up histology, including four squamous cell carcinomas. Among the cytomorphological features examined, nuclear membrane irregularity, three-dimensional clusters, single-cell pattern, and presence of mitoses were associated with malignant histology in follow-up.
Conclusions
This study showed our institute’s experience detecting glandular abnormalities in cervical cytology over a 25-year period, revealing the difficulty of this task. Nonetheless, the present study indicates that several cytological findings such as membrane irregularity, three-dimensional clusters, single-cell pattern, and evidence of proliferation could help distinguishing malignancy from a benign lesion.

Citations

Citations to this article as recorded by  
  • Analysis of atypical glandular cells in ThinPrep Pap smear and follow-up histopathology
    Tengfei Wang, Yinan Hua, Lina Liu, Bing Leng
    Baylor University Medical Center Proceedings.2024; 37(3): 403.     CrossRef
Article image
Evaluation of the characteristics of multiple human papillomavirus (HPV) infections identified using the BD Onclarity HPV assay and comparison with those of single HPV infection
Jinhee Kim, Moonsik Kim, Ji Young Park
J Pathol Transl Med. 2022;56(5):289-293.   Published online September 13, 2022
DOI: https://doi.org/10.4132/jptm.2022.08.02
  • 4,759 View
  • 122 Download
  • 8 Web of Science
  • 7 Crossref
AbstractAbstract PDFSupplementary Material
Background
Human papillomavirus (HPV) infection is a major cause of cervical cancer and associated precursor lesions. Multiple HPV genotype infections have been reported. However, their clinicopathological characteristics still remain elusive.
Methods
For this study, 814 consecutive patients who had undergone colposcopy and HPV genotyping test using BD Onclarity HPV assay were retrospectively selected. Clinicopathological parameters of multiple HPV infections were compared with those of single HPV infection.
Results
Multiple HPV infections were found in 110 out of 814 cases (13.5%). Multiple HPV infections were associated with a significantly higher incidence of high-grade intraepithelial lesions (HSILs) compared with single HPV infection. Other high-risk HPV genotypes, in addition to HPV 16, were found more frequently in the multiple HPV infections group; these included HPV 51, 52, 33/58, 56/59/66, and 35/39/68. No specific coinfection pattern was not identified. Additionally, the number of HPV genotypes in multiple HPV infections was not associated with the progression to HSIL or squamous cell carcinoma.
Conclusions
Multiple HPV infections have distinct clinicopathological characteristics (compared with single HPV infection). As their biological behavior is uncertain, close and frequent follow-up is warranted.

Citations

Citations to this article as recorded by  
  • The Prevalence of Multi-Type Infections Among Human Papillomavirus Types in Korean Women
    Jang Mook Kim, Hee Seung Song, Jieun Hwang, Jae Kyung Kim
    Pathogens.2025; 14(4): 369.     CrossRef
  • The cervical cancer related distribution, coinfection and risk of 15 HPV types in Baoan, Shenzhen, in 2017–2023
    Rukai Li, Weiwei Meng, Yunhai Zuo, Yanli Xu, Shaonan Wu
    Virology Journal.2024;[Epub]     CrossRef
  • Molecular findings and virological assessment of bladder papillomavirus infection in cattle
    Francesca De Falco, Anna Cutarelli, Francesca Luisa Fedele, Cornel Catoi, Sante Roperto
    Veterinary Quarterly.2024; 44(1): 1.     CrossRef
  • Patterns of single and multiple HPV infections in female: A systematic review and meta-analysis
    Dan Zhou, Jing Xue, Yaqiong Sun, Liling Zhu, Ming Zhao, Meimei Cui, Min Zhang, Jingjing Jia, Limei Luo
    Heliyon.2024; 10(17): e35736.     CrossRef
  • Age distribution of patients with multiple High-Risk Human Papilloma Virus (HR-HPV) genotypes and HPV vaccine recommendations by age
    Gülçin Çetin Uysal, Nil Tekin
    Family Practice and Palliative Care.2024; 9(3): 80.     CrossRef
  • Relative distribution of HPV genotypes in histological cervical samples and associated grade lesion in a women population over the last 16 years in Burgundy, France
    Christelle Auvray, Serge Douvier, Odile Caritey, Jean-Baptiste Bour, Catherine Manoha
    Frontiers in Medicine.2023;[Epub]     CrossRef
  • Epidemiologic characteristics of high-risk HPV and the correlation between multiple infections and cervical lesions
    Qinli Luo, Xianghua Zeng, Hanyi Luo, Ling Pan, Ying Huang, Haiyan Zhang, Na Han
    BMC Infectious Diseases.2023;[Epub]     CrossRef
Prognostic Significance of CD109 Expression in Patients with Ovarian Epithelial Cancer
So Young Kim, Kyung Un Choi, Chungsu Hwang, Hyung Jung Lee, Jung Hee Lee, Dong Hoon Shin, Jee Yeon Kim, Mee Young Sol, Jae Ho Kim, Ki Hyung Kim, Dong Soo Suh, Byung Su Kwon
J Pathol Transl Med. 2019;53(4):244-252.   Published online May 2, 2019
DOI: https://doi.org/10.4132/jptm.2019.04.16
  • 7,195 View
  • 126 Download
  • 7 Web of Science
  • 6 Crossref
AbstractAbstract PDF
Background
Ovarian epithelial cancer (OEC) is the second-most common gynecologic malignancy. CD109 expression is elevated in human tumor cell lines and carcinomas. A previous study showed that CD109 expression is elevated in human tumor cell lines and CD109 plays a role in cancer progression. Therefore, this study aimed to determine whether CD109 is expressed in OEC and can be useful in predicting the prognosis.
Methods
Immunohistochemical staining for CD109 and reverse transcription-quantitative polymerase chain reaction was performed. Then we compared CD109 expression and chemoresistance, overall survival, and recurrence-free survival of OEC patients. Chemoresistance was evaluated by dividing into good-response group and poor-response group by the time to recurrence after chemotherapy.
Results
CD109 expression was associated with overall survival (p = .020), but not recurrence-free survival (p = .290). CD109 expression was not an independent risk factor for overall survival due to its reliability (hazard ratio, 1.58; p = .160; 95% confidence interval, 0.82 to 3.05), although we found that CD109 positivity was related to chemoresistance. The poor-response group showed higher rates of CD109 expression than the good-response group (93.8% vs 66.7%, p = .047). Also, the CD109 mRNA expression level was 2.88 times higher in the poor-response group as compared to the good-response group (p = .001).
Conclusions
Examining the CD109 expression in patients with OEC may be helpful in predicting survival and chemotherapeutic effect.

Citations

Citations to this article as recorded by  
  • Advances in the Study of CD109 in Tumors
    平慧 周
    Medical Diagnosis.2024; 14(02): 167.     CrossRef
  • Identification of CD109 in the extracellular vesicles derived from ovarian cancer stem-like cells
    Ye Eun Kim, Jun Se Kim, Min Joo Shin, Seo Yul Lee, Dae Kyoung Kim, Nam-Kyung Lee, Yang Woo Kwon, Kyung-Un Choi, Dong-Soo Suh, Byoung Soo Kim, Sanghwa Jeong, Jae Ho Kim
    BMB Reports.2024; 57(12): 527.     CrossRef
  • CD109 Promotes Drug Resistance in A2780 Ovarian Cancer Cells by Regulating the STAT3-NOTCH1 Signaling Axis
    Jun Se Kim, Min Joo Shin, Seo Yul Lee, Dae Kyoung Kim, Kyung-Un Choi, Dong-Soo Suh, Dayea Kim, Jae Ho Kim
    International Journal of Molecular Sciences.2023; 24(12): 10306.     CrossRef
  • CD109 facilitates progression and 5-fluorouracil resistance of nasopharyngeal carcinoma
    Zhenwei Zhu, Fang Zhou, Cheng Mao
    Materials Express.2022; 12(9): 1189.     CrossRef
  • Usefulness of CD109 expression as a prognostic biomarker in patients with cancer
    Hyun Min Koh, Hyun Ju Lee, Dong Chul Kim
    Medicine.2021; 100(11): e25006.     CrossRef
  • Serum CD109 levels reflect the node metastasis status in head and neck squamous cell carcinoma
    Sumitaka Hagiwara, Eiichi Sasaki, Yasuhisa Hasegawa, Hidenori Suzuki, Daisuke Nishikawa, Shintaro Beppu, Hoshino Terada, Michi Sawabe, Masahide Takahashi, Nobuhiro Hanai
    Cancer Medicine.2021; 10(4): 1335.     CrossRef
Review
Pathogenesis of Focal Segmental Glomerulosclerosis
Beom Jin Lim, Jae Won Yang, Woo Sung Do, Agnes B. Fogo
J Pathol Transl Med. 2016;50(6):405-410.   Published online October 16, 2016
DOI: https://doi.org/10.4132/jptm.2016.09.21
  • 14,663 View
  • 883 Download
  • 52 Web of Science
  • 48 Crossref
AbstractAbstract PDF
Focal segmental glomerulosclerosis (FSGS) is characterized by focal and segmental obliteration of glomerular capillary tufts with increased matrix. FSGS is classified as collapsing, tip, cellular, perihilar and not otherwise specified variants according to the location and character of the sclerotic lesion. Primary or idiopathic FSGS is considered to be related to podocyte injury, and the pathogenesis of podocyte injury has been actively investigated. Several circulating factors affecting podocyte permeability barrier have been proposed, but not proven to cause FSGS. FSGS may also be caused by genetic alterations. These genes are mainly those regulating slit diaphragm structure, actin cytoskeleton of podocytes, and foot process structure. The mode of inheritance and age of onset are different according to the gene involved. Recently, the role of parietal epithelial cells (PECs) has been highlighted. Podocytes and PECs have common mesenchymal progenitors, therefore, PECs could be a source of podocyte repopulation after podocyte injury. Activated PECs migrate along adhesion to the glomerular tuft and may also contribute to the progression of sclerosis. Markers of activated PECs, including CD44, could be used to distinguish FSGS from minimal change disease. The pathogenesis of FSGS is very complex; however, understanding basic mechanisms of podocyte injury is important not only for basic research, but also for daily diagnostic pathology practice.

Citations

Citations to this article as recorded by  
  • miRNAs involved in the TGFB signaling as possible markers of steroid-resistant nephrotic syndrome in children
    Ahmedz Widiasta, Yunia Sribudiani, Husna Nugrahapraja, Dedi Rachmadi
    Gene Reports.2025; 39: 102173.     CrossRef
  • Purinergic Receptor Activation Protects Glomerular Microvasculature from Increased Mechanical Stress in Angiotensin II-Induced Hypertension: A Modeling Study
    Owen Richfield, Ricardo Cortez, Supaporn Kulthinee, Martha Franco, L. Gabriel Navar
    International Journal of Molecular Sciences.2025; 26(5): 1928.     CrossRef
  • Podocyte A20/TNFAIP3 Controls Glomerulonephritis Severity via the Regulation of Inflammatory Responses and Effects on the Cytoskeleton
    Paulina Köhler, Andrea Ribeiro, Mohsen Honarpisheh, Ekaterina von Rauchhaupt, Georg Lorenz, Chenyu Li, Lucas Martin, Stefanie Steiger, Maja Lindenmeyer, Christoph Schmaderer, Hans-Joachim Anders, Dana Thomasova, Maciej Lech
    Cells.2025; 14(5): 381.     CrossRef
  • Clinical implications of apolipoprotein L1 testing in patients with focal segmental glomerulosclerosis: a review of diagnostic and prognostic implications
    Aiman Waheed, Muhammad Hamza Gul, Risha Naeem, Sardar Noman Qayyum, Khizra Batool, Abeeha Shaukat, Nashmiya Khan, Safa Irfan Shah, Aisha Rehman Siddiqui, Asad Ullah Farooq, Eeshah Nasir, Samim Noori
    Annals of Medicine & Surgery.2025; 87(3): 1543.     CrossRef
  • Focal segmental glomerulosclerosis associated with undescribed mutation in the LMX1B gene
    María Adoración Martín Gómez, Mercedes Caba Molina, Miriam León Fradejas, Juana Alonso Titos, Rafael del Pozo Alvarez
    European Journal of Medical Genetics.2024; 72: 104980.     CrossRef
  • MicroRNA-155-5p Aggravates Adriamycin-Induced Focal Segmental Glomerulosclerosis through Targeting Nrf2
    Guoyong Liu, Liyu He, Xiaomeng Yang, Lingling Tang, Wei Shi, Jian She, Jiali Wei
    Nephron.2023; 147(2): 108.     CrossRef
  • The role of HLA antigens in recurrent primary focal segmental glomerulosclerosis
    Ibrahim Batal, Pascale Khairallah, Astrid Weins, Nicole K. Andeen, Michael B. Stokes
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • IgM and C3 Deposition in Primary Focal Segmental Glomerulosclerosis (FSGS): A Clinical and Histopathological Spectrum
    Faizan Amer, Madiha Syed , Aurangzeb Afzal, Mudassar Hussain , Usman Hassan, Shaarif Bashir, Maryam Hameed, Sheeba Ishtiaq
    Cureus.2023;[Epub]     CrossRef
  • Identification of key biomarkers of the glomerulus in focal segmental glomerulosclerosis and their relationship with immune cell infiltration based on WGCNA and the LASSO algorithm
    Yun Xia Zhang, Juan Lv, Jun Yuan Bai, XiaoWei Pu, En Lai Dai
    Renal Failure.2023;[Epub]     CrossRef
  • Rituximab in the treatment of primary FSGS: time for its use in routine clinical practice?
    Adam D Morris, Lauren Floyd, Alexander Woywodt, Ajay Dhaygude
    Clinical Kidney Journal.2023; 16(8): 1199.     CrossRef
  • High Rate of Mutations of Adhesion Molecules and Extracellular Matrix Glycoproteins in Patients with Adult-Onset Focal and Segmental Glomerulosclerosis
    Sara Marcos González, Emilio Rodrigo Calabia, Ignacio Varela, Michal Červienka, Javier Freire Salinas, José Javier Gómez Román
    Biomedicines.2023; 11(6): 1764.     CrossRef
  • Glomerular parietal epithelial expression of CD44 in minimal change nephrotic syndrome and primary focal segmental glomerulosclerosis: A clinico-pathological study
    ENithin Paul, Suchitha Satish, KiranKrishnamurthy Kelur, ManjunathSanjeev Shetty
    Indian Journal of Pathology and Microbiology.2023; 66(3): 526.     CrossRef
  • Calcineurin inhibitors or cyclophosphamide in the treatment of membranous nephropathy superimposed with FSGS lesions: a retrospective study from China
    Hong-Guang He, Yi-Yun Huang, Qin-Qing Liang, Qiu-Rong Ye, An-Dong Li, Kun Ye, Qiu-Xia Wu, Yan-Wu You
    Renal Failure.2023;[Epub]     CrossRef
  • CD44-negative parietal–epithelial cell staining in minimal change disease: association with clinical features, response to corticosteroids and kidney outcome
    Neus Roca, Elias Jatem, Anabel Abo, Maria Santacana, Alejandro Cruz, Álvaro Madrid, Gloria Fraga, Marisa Martin, Jorge Gonzalez, Cristina Martinez, Anna Balius, Alfons Segarra
    Clinical Kidney Journal.2022; 15(3): 545.     CrossRef
  • Monogenic focal segmental glomerulosclerosis: A conceptual framework for identification and management of a heterogeneous disease
    Meenakshi Sambharia, Prerna Rastogi, Christie P. Thomas
    American Journal of Medical Genetics Part C: Seminars in Medical Genetics.2022; 190(3): 377.     CrossRef
  • Small Nucleolar RNAs in Pseudoexfoliation Glaucoma
    Karolina Gasińska, Marcin Czop, Ewa Kosior-Jarecka, Dominika Wróbel-Dudzińska, Janusz Kocki, Tomasz Żarnowski
    Cells.2022; 11(17): 2738.     CrossRef
  • Collapsing focal segmental glomerulosclerosis in a patient with oral cavity cancer
    Sae Byeol Choi, Kyoung Min Kim, Moon Hyang Park, Kyung Pyo Kang
    Medicine.2021; 100(18): e25857.     CrossRef
  • MRTF: Basic Biology and Role in Kidney Disease
    Maria Zena Miranda, Zsuzsanna Lichner, Katalin Szászi, András Kapus
    International Journal of Molecular Sciences.2021; 22(11): 6040.     CrossRef
  • The Unique Difference Between Serum Level of Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Steroid-Resistant Nephrotic Syndrome Children Treated with an Alkylating Agent and Calcineurin Inhibitors
    Ahmedz Widiasta, Kurnia Wahyudi, Husna Nugrahapraja, Yunia Sribudiani, Dedi Rachmadi
    Journal of Comprehensive Pediatrics.2021;[Epub]     CrossRef
  • Recessive, gain-of-function toxicity in an APOL1 BAC transgenic mouse model mirrors human APOL1 kidney disease
    Gizelle M. McCarthy, Angelo Blasio, Olivia G. Donovan, Lena B. Schaller, Althea Bock-Hughes, Jose M. Magraner, Jung Hee Suh, Calum F. Tattersfield, Isaac E. Stillman, Shrijal S. Shah, Zsuzsanna K. Zsengeller, Balajikarthick Subramanian, David J. Friedman,
    Disease Models & Mechanisms.2021;[Epub]     CrossRef
  • CLEC14A protects against podocyte injury in mice with adriamycin nephropathy
    Zeyu Su, Yujia Li, Hang Lv, Xiaoyang Cui, Min Liu, Ziying Wang, Yan Zhang, Junhui Zhen, Wei Tang, Xiaojie Wang, Fan Yi
    The FASEB Journal.2021;[Epub]     CrossRef
  • Interplay between extracellular matrix components and cellular and molecular mechanisms in kidney fibrosis
    Sandra Rayego-Mateos, Sofia Campillo, Raúl R. Rodrigues-Diez, Antonio Tejera-Muñoz, Laura Marquez-Exposito, Roel Goldschmeding, Diego Rodríguez-Puyol, Laura Calleros, Marta Ruiz-Ortega
    Clinical Science.2021; 135(16): 1999.     CrossRef
  • The recruitment mechanisms and potential therapeutic targets of podocytes from parietal epithelial cells
    Lihua Ni, Cheng Yuan, Xiaoyan Wu
    Journal of Translational Medicine.2021;[Epub]     CrossRef
  • miR-150 inhibitor ameliorates adriamycin-induced focal segmental glomerulosclerosis
    Huimeng Qi, Jingqi Fu, Junjun Luan, Congcong Jiao, Xiangfei Cui, Xiangyan Cao, Yixiao Zhang, Yanqiu Wang, Jeffrey B. Kopp, Jingbo Pi, Hua Zhou
    Biochemical and Biophysical Research Communications.2020; 522(3): 618.     CrossRef
  • From protein uptake to Dent disease: An overview of the CLCN5 gene
    Lisa Gianesello, Dorella Del Prete, Monica Ceol, Giovanna Priante, Lorenzo Arcangelo Calò, Franca Anglani
    Gene.2020; 747: 144662.     CrossRef
  • Non-ischemic cardiomyopathy with focal segmental glomerulosclerosis
    Parminder Kaur, Balraj Singh, Prem Patel, Rahul Vasudev, Upamanyu Rampal, Fayez Shamoon
    Journal of Community Hospital Internal Medicine Perspectives.2020; 10(2): 154.     CrossRef
  • Glomerular Endothelial Cells as Instigators of Glomerular Sclerotic Diseases
    Marloes Sol, Jan A. A. M. Kamps, Jacob van den Born, Marius C. van den Heuvel, Johan van der Vlag, Guido Krenning, Jan-Luuk Hillebrands
    Frontiers in Pharmacology.2020;[Epub]     CrossRef
  • A novel heterozygous variant of the COL4A4 gene in a Chinese family with hematuria and proteinuria leads to focal segmental glomerulosclerosis and chronic kidney disease
    Liang‐Liang Fan, Lv Liu, Fang‐Mei Luo, Ran Du, Chen‐Yu Wang, Yi Dong, Ji‐Shi Liu
    Molecular Genetics & Genomic Medicine.2020;[Epub]     CrossRef
  • Cellular and molecular mechanisms of kidney fibrosis
    Sonja Djudjaj, Peter Boor
    Molecular Aspects of Medicine.2019; 65: 16.     CrossRef
  • Albumin induces CD44 expression in glomerular parietal epithelial cells by activating extracellular signal‐regulated kinase 1/2 pathway
    Xueying Zhao, Xiaoming Chen, Ashmeer Chima, Yuanyuan Zhang, Jasmine George, Alyssa Cobbs, Nerimiah Emmett
    Journal of Cellular Physiology.2019; 234(5): 7224.     CrossRef
  • Analysis of the genomic architecture of a complex trait locus in hypertensive rat models links Tmem63c to kidney damage
    Angela Schulz, Nicola Victoria Müller, Nina Anne van de Lest, Andreas Eisenreich, Martina Schmidbauer, Andrei Barysenka, Bettina Purfürst, Anje Sporbert, Theodor Lorenzen, Alexander M Meyer, Laura Herlan, Anika Witten, Frank Rühle, Weibin Zhou, Emile de H
    eLife.2019;[Epub]     CrossRef
  • Podocyte-Specific Sialylation-Deficient Mice Serve as a Model for Human FSGS
    Kristina M. Niculovic, Linda Blume, Henri Wedekind, Elina Kats, Iris Albers, Stephanie Groos, Markus Abeln, Jessica Schmitz, Esther Beuke, Jan H. Bräsen, Anette Melk, Mario Schiffer, Birgit Weinhold, Anja K. Münster-Kühnel
    Journal of the American Society of Nephrology.2019; 30(6): 1021.     CrossRef
  • Inhibition of the ERK1/2-mTORC1 axis ameliorates proteinuria and the fibrogenic action of transforming growth factor-β in Adriamycin-induced glomerulosclerosis
    Ranjan Das, Soo-Jin Kim, Nhung Thi Nguyen, Hyeong Ju Kwon, Seung-Kuy Cha, Kyu-Sang Park
    Kidney International.2019; 96(4): 927.     CrossRef
  • Mechanisms of Scarring in Focal Segmental Glomerulosclerosis
    Jianyong Zhong, Jacob B. Whitman, Hai-Chun Yang, Agnes B. Fogo
    Journal of Histochemistry & Cytochemistry.2019; 67(9): 623.     CrossRef
  • A bigenic mouse model of FSGS reveals perturbed pathways in podocytes, mesangial cells and endothelial cells
    Andrew S. Potter, Keri Drake, Eric W. Brunskill, S. Steven Potter, Peter Hohenstein
    PLOS ONE.2019; 14(8): e0216261.     CrossRef
  • Chronic kidney disease: a review of proteomic and metabolomic approaches to membranous glomerulonephritis, focal segmental glomerulosclerosis, and IgA nephropathy biomarkers
    Amir Taherkhani, Reyhaneh Farrokhi Yekta, Maede Mohseni, Massoud Saidijam, Afsaneh Arefi Oskouie
    Proteome Science.2019;[Epub]     CrossRef
  • Sphingolipid signaling in renal fibrosis
    Andrea Huwiler, Josef Pfeilschifter
    Matrix Biology.2018; 68-69: 230.     CrossRef
  • A novel assay provides sensitive measurement of physiologically relevant changes in albumin permeability in isolated human and rodent glomeruli
    Sara Desideri, Karen L. Onions, Yan Qiu, Raina D. Ramnath, Matthew J. Butler, Christopher R. Neal, Matthew L.R. King, Andrew E. Salmon, Moin A. Saleem, Gavin I. Welsh, C. Charles Michel, Simon C. Satchell, Andrew H.J. Salmon, Rebecca R. Foster
    Kidney International.2018; 93(5): 1086.     CrossRef
  • Recent advances of animal model of focal segmental glomerulosclerosis
    Jae Won Yang, Anne Katrin Dettmar, Andreas Kronbichler, Heon Yung Gee, Moin Saleem, Seong Heon Kim, Jae Il Shin
    Clinical and Experimental Nephrology.2018; 22(4): 752.     CrossRef
  • Urinary podocyte-associated molecules and albuminuria in hypertension
    Javier Perez-Hernandez, Maria D. Olivares, Elena Solaz, Fernando Martinez, Sergio Martínez-Hervas, Gernot Pichler, Felipe J. Chaves, Josep Redon, Raquel Cortes
    Journal of Hypertension.2018; 36(8): 1712.     CrossRef
  • Segmental Sclerosis and Extracapillary Hypercellularity Predict Diabetic ESRD
    Amy K. Mottl, Adil Gasim, Fernanda Payan Schober, Yichun Hu, Askia K. Dunnon, Susan L. Hogan, J. Charles Jennette
    Journal of the American Society of Nephrology.2018; 29(2): 694.     CrossRef
  • Chlormethine Hydrochloride is Not Inferior to Tacrolimus in Treating Steroid-Resistant Nephrotic Syndrome
    Yuan Yang, Li Zhao, Li Xiao, Yumei Liang, Chang Wang, Xiao Fu, Xuejing Zhu, Shuguang Yuan, Jianling Zhu, Xiaoping Zhu, Yinghong Liu, Jun Li, Jian Luo, Fuyou Liu, Lin Sun
    Kidney and Blood Pressure Research.2018; 43(1): 68.     CrossRef
  • Can podocytes be regenerated in adults?
    Stuart J. Shankland, Benjamin S. Freedman, Jeffrey W. Pippin
    Current Opinion in Nephrology and Hypertension.2017; 26(3): 154.     CrossRef
  • Plasma exchange in kidney transplantation: Still a valuable option for nephrotic syndrome recurrence
    Licia Peruzzi, Roberto Albiani, Karol Giancaspero
    Transfusion and Apheresis Science.2017; 56(4): 525.     CrossRef
  • Is CD44 in glomerular parietal epithelial cells a pathological marker of renal function deterioration in primary focal segmental glomerulosclerosis?
    Brunna Pinto Froes, Stanley de Almeida Araújo, Eduardo Alves Bambirra, Eduardo Araújo Oliveira, Ana Cristina Simões e Silva, Sérgio Veloso Brant Pinheiro
    Pediatric Nephrology.2017; 32(11): 2165.     CrossRef
  • Injury-induced actin cytoskeleton reorganization in podocytes revealed by super-resolution microscopy
    Hani Y. Suleiman, Robyn Roth, Sanjay Jain, John E. Heuser, Andrey S. Shaw, Jeffrey H. Miner
    JCI Insight.2017;[Epub]     CrossRef
  • Resveratrol Attenuates Adriamycin-Induced Focal Segmental Glomerulosclerosis through C3aR/C5aR- Sphingosine Kinase 1 Pathway
    Guoyong Liu, Qiang Wang, Yan Shi, Xiaofei Peng, Hong Liu, Youming Peng, Liyu He
    Pharmacology.2017; 100(5-6): 253.     CrossRef
  • The Multifaceted Role of the Lysosomal Protease Cathepsins in Kidney Disease
    Pasquale Cocchiaro, Valeria De Pasquale, Rossella Della Morte, Simona Tafuri, Luigi Avallone, Anne Pizard, Anna Moles, Luigi Michele Pavone
    Frontiers in Cell and Developmental Biology.2017;[Epub]     CrossRef
Original Articles
Clinicopathologic Correlations of E-cadherin and Prrx-1 Expression Loss in Hepatocellular Carcinoma
Kijong Yi, Hyunsung Kim, Yumin Chung, Hyein Ahn, Jongmin Sim, Young Chan Wi, Ju Yeon Pyo, Young-Soo Song, Seung Sam Paik, Young-Ha Oh
J Pathol Transl Med. 2016;50(5):327-336.   Published online August 31, 2016
DOI: https://doi.org/10.4132/jptm.2016.06.22
  • 10,010 View
  • 165 Download
  • 4 Web of Science
  • 3 Crossref
AbstractAbstract PDF
Background
Developing predictive markers for hepatocellular carcinoma (HCC) is important, because many patients experience recurrence and metastasis. Epithelial to mesenchymal transition (EMT) is a developmental process that plays an important role during embryogenesis and also during cancer metastasis. Paired-related homeobox protein 1 (Prrx-1) is an EMT inducer that has recently been introduced, and its prognostic significance in HCC is largely unknown.
Methods
Tissue microarray was constructed using surgically resected primary HCCs from 244 cases. Immunohistochemical staining of E-cadherin and Prrx-1 was performed. The correlation between E-cadherin loss and Prrx-1 expression, as well as other clinicopathologic factors, was evaluated.
Results
E-cadherin expression was decreased in 96 cases (39.4%). Loss of E-cadherin correlated with a higher recurrence rate (p < .001) but was not correlated with patient’s survival. Thirty-two cases (13.3%) showed at least focal nuclear Prrx-1 immunoreactivity while all non-neoplastic livers (n = 22) were negative. Prrx-1 expression was not associated with E-cadherin loss, survival or recurrence rates, pathologic factors, or the Ki-67 labeling index. Twenty tumors that were positive for E-cadherin and Prrx-1 had significantly higher nuclear grades than the rest of the cohort (p = .037). In Cox proportional hazard models, E-cadherin loss and large vessel invasion were independent prognostic factors for shorter disease-free survival. Cirrhosis and high Ki-67 index (> 40%) were independent prognostic factors for shorter overall survival.
Conclusions
Prrx-1 was expressed in small portions of HCCs but not in normal livers. Additional studies with a large number of Prrx-1-positive cases are required to confirm the results of this study.

Citations

Citations to this article as recorded by  
  • The Prognostic Importance of Ki-67 in Gastrointestinal Carcinomas: A Meta-analysis and Multi-omics Approach
    Mahdieh Razmi, Fatemeh Tajik, Farideh Hashemi, Ayna Yazdanpanah, Fatemeh Hashemi-Niasari, Adeleh Divsalar
    Journal of Gastrointestinal Cancer.2024; 55(2): 599.     CrossRef
  • Homotypic cell-in-cell structures as an adverse prognostic predictor of hepatocellular carcinoma
    Ruizhi Wang, Yichao Zhu, Hao Zhong, Xinyue Gao, Qiang Sun, Meifang He
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Dysregulated paired related homeobox 1 impacts on hepatocellular carcinoma phenotypes
    Weronika Piorońska, Zeribe Chike Nwosu, Mei Han, Michael Büttner, Matthias Philip Ebert, Steven Dooley, Christoph Meyer
    BMC Cancer.2021;[Epub]     CrossRef
Clinical Significance of an HPV DNA Chip Test with Emphasis on HPV-16 and/or HPV-18 Detection in Korean Gynecological Patients
Min-Kyung Yeo, Ahwon Lee, Soo Young Hur, Jong Sup Park
J Pathol Transl Med. 2016;50(4):294-299.   Published online June 26, 2016
DOI: https://doi.org/10.4132/jptm.2016.05.09
  • 9,050 View
  • 80 Download
  • 3 Web of Science
  • 2 Crossref
AbstractAbstract PDF
Background
Human papillomavirus (HPV) is a major risk factor for cervical cancer.
Methods
We evaluated the clinical significance of the HPV DNA chip genotyping assay (MyHPV chip, Mygene Co.) compared with the Hybrid Capture 2 (HC2) chemiluminescent nucleic acid hybridization kit (Digene Corp.) in 867 patients.
Results
The concordance rate between the MyHPV chip and HC2 was 79.4% (kappa coefficient, κ = 0.55). The sensitivity and specificity of both HPV tests were very similar (approximately 85% and 50%, respectively). The addition of HPV result (either MyHPV chip or HC2) to cytology improved the sensitivity (95%, each) but reduced the specificity (approximately 30%, each) compared with the HPV test or cytology alone. Based on the MyHPV chip results, the odds ratio (OR) for ≥ high-grade squamous intraepithelial lesions (HSILs) was 9.9 in the HPV-16/18 (+) group and 3.7 in the non-16/18 high-risk (HR)-HPV (+) group. Based on the HC2 results, the OR for ≥ HSILs was 5.9 in the HR-HPV (+) group. When considering only patients with cytological diagnoses of “negative for intraepithelial lesion or malignancy” and “atypical squamous cell or atypical glandular cell,” based on the MyHPV chip results, the ORs for ≥ HSILs were 6.8 and 11.7, respectively, in the HPV-16/18 (+) group.
Conclusions
The sensitivity and specificity of the MyHPV chip test are similar to the HC2. Detecting HPV-16/18 with an HPV DNA chip test, which is commonly used in many Asian countries, is useful in assessing the risk of high-grade cervical lesions.

Citations

Citations to this article as recorded by  
  • Human papilloma virus identification in ocular surface squamous neoplasia by p16 immunohistochemistry and DNA chip test
    Tina Shrestha, Won Choi, Ga Eon Kim, Jee Myung Yang, Kyung Chul Yoon
    Medicine.2019; 98(2): e13944.     CrossRef
  • Comparison of the PANArray HPV Genotyping Chip Test with the Cobas 4800 HPV and Hybrid Capture 2 Tests for Detection of HPV in ASCUS Women
    Eun Young Ki, Yoon Kyung Lee, Ahwon Lee, Jong Sup Park
    Yonsei Medical Journal.2018; 59(5): 662.     CrossRef
Significance of Parafibromin Expression in Laryngeal Squamous Cell Carcinomas
Inju Cho, Mija Lee, Sharon Lim, Ran Hong
J Pathol Transl Med. 2016;50(4):264-269.   Published online June 23, 2016
DOI: https://doi.org/10.4132/jptm.2016.04.24
  • 9,279 View
  • 61 Download
  • 6 Web of Science
  • 4 Crossref
AbstractAbstract PDF
Background
Parafibromin is a product of the tumor suppressor gene that has been studied as a potential indicator of tumor aggressiveness in the parathyroid, breast, colorectum, and stomach. However, the clinical significance and potential function of parafibromin expression in head and neck squamous cell carcinomas remain largely unknown. The aim of this study was to evaluate the expression of parafibromin in laryngeal squamous cell carcinoma (LSCC) and to verify its potential as a biomarker of tumor behavior.
Methods
Parafibromin expression was evaluated in 30 cases of LSCC using immunohistochemistry. The correlations between parafibromin expression and clinicopathologic parameters were investigated.
Results
Parafibromin expression was positive in 15 cases (50%) and negative in 15 cases (50%). Tumor size and T stage showed a statistically significant inverse relationship with parafibromin expression (p=.028 and p<.001, respectively). Parafibromin expression was not associated with age, sex, lymph node metastasis, tumor differentiation, or tumor location. There was no statistically significant relationship between parafibromin expression and progression-free survival in the patients (p>.05).
Conclusions
Our results indicate that the downregulation or loss of parafibromin expression can be employed as a novel marker of tumor progression or aggressiveness in LSCC.

Citations

Citations to this article as recorded by  
  • CDC73 c.1155-3A>G is a pathogenic variant that causes aberrant splicing, disrupted parafibromin expression, and hyperparathyroidism-jaw tumor syndrome
    Leor Needleman, Nicolette Chun, Sathvika Sitaraman, Marilyn Tan, Deborah E Sellmeyer, Electron Kebebew, Justin P Annes
    JBMR Plus.2024;[Epub]     CrossRef
  • Advances in the application of label‐free quantitative proteomics techniques in malignancy research
    Xiao Meng, Dong Liu, Yan Guan
    Biomedical Chromatography.2023;[Epub]     CrossRef
  • The roles of the tumor suppressor parafibromin in cancer
    Hua-chuan Zheng, Hang Xue, Cong-yu Zhang
    Frontiers in Cell and Developmental Biology.2022;[Epub]     CrossRef
  • The clinicopathological and prognostic significances of CDC73 expression in cancers: a bioinformatics analysis
    Hua-Chuan Zheng, Bao-Cheng Gong, Shuang Zhao
    Oncotarget.2017; 8(56): 95270.     CrossRef
Aquaporin 1 Is an Independent Marker of Poor Prognosis in Lung Adenocarcinoma
Sumi Yun, Ping-Li Sun, Yan Jin, Hyojin Kim, Eunhyang Park, Soo Young Park, Kyuho Lee, Kyoungyul Lee, Jin-Haeng Chung
J Pathol Transl Med. 2016;50(4):251-257.   Published online June 7, 2016
DOI: https://doi.org/10.4132/jptm.2016.03.30
  • 10,427 View
  • 122 Download
  • 22 Web of Science
  • 22 Crossref
AbstractAbstract PDF
Background
Aquaporin 1 (AQP1) overexpression has been shown to be associated with uncontrolled cell replication, invasion, migration, and tumor metastasis. We aimed to evaluate AQP1 expression in lung adenocarcinomas and to examine its association with clinicopathological features and prognostic significance. We also investigated the association between AQP1 overexpression and epithelial-mesenchymal transition (EMT) markers.
Methods
We examined AQP1 expression in 505 cases of surgically resected lung adenocarcinomas acquired at the Seoul National University Bundang Hospital from 2003 to 2012. Expression of AQP1 and EMT-related markers, including Ecadherin and vimentin, were analyzed by immunohistochemistry and tissue microarray.
Results
AQP1 overexpression was associated with several aggressive pathological parameters, including venous invasion, lymphatic invasion, and tumor recurrence. AQP1 overexpression tended to be associated with higher histological grade, advanced pathological stage, and anaplastic lymphoma kinase (ALK) translocation; however, these differences were not statistically significant. In addition, AQP1 overexpression positively correlated with loss of E-cadherin expression and acquired expression of vimentin. Lung adenocarcinoma patients with AQP1 overexpression showed shorter progression- free survival (PFS, 46.1 months vs. 56.2 months) compared to patients without AQP1 overexpression. Multivariate analysis confirmed that AQP1 overexpression was significantly associated with shorter PFS (hazard ratio, 1.429; 95% confidence interval, 1.033 to 1.977; p=.031).
Conclusions
AQP1 overexpression was thereby concluded to be an independent factor of poor prognosis associated with shorter PFS in lung adenocarcinoma. These results suggested that AQP1 overexpression might be considered as a prognostic biomarker of lung adenocarcinoma.

Citations

Citations to this article as recorded by  
  • The Expanding Role of Aquaporin-1, Aquaporin-3 and Aquaporin-5 as Transceptors: Involvement in Cancer Development and Potential Druggability
    Catarina Pimpão, Inês V. da Silva, Graça Soveral
    International Journal of Molecular Sciences.2025; 26(3): 1330.     CrossRef
  • The comprehensive potential of AQP1 as a tumor biomarker: evidence from kidney neoplasm cohorts, cell experiments and pan-cancer analysis
    Yifan Liu, Donghao Lyu, Yuntao Yao, Jinming Cui, Jiangui Liu, Zikuan Bai, Zihui Zhao, Yuanan Li, Bingnan Lu, Keqin Dong, Xiuwu Pan
    Human Genomics.2025;[Epub]     CrossRef
  • The Association of Aquaporins with MAPK Signaling Pathway Unveils Potential Prognostic Biomarkers for Pancreatic Cancer: A Transcriptomics Approach
    Inês V. da Silva, Paula A. Lopes, Elisabete Fonseca, Emanuel Vigia, Jorge Paulino, Graça Soveral
    Biomolecules.2025; 15(4): 488.     CrossRef
  • Clinical application of cold atmospheric-pressure plasma: mechanisms and irradiation conditions
    Eun Ji Jeong, Hyun Min Park, Dong Jae Lee, Jun Lee, Jun Yeong Cho, Kyung Deok Seo, Seokjun Je, Min Hyung Jung, Woo Yeon Hwang, Kyung Sook Kim
    Journal of Physics D: Applied Physics.2024; 57(37): 373001.     CrossRef
  • Aquaporins in Cancer Biology
    Chul So Moon, David Moon, Sung Koo Kang
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • A Comprehensive Prognostic Analysis of Tumor-Related Blood Group Antigens in Pan-Cancers Suggests That SEMA7A as a Novel Biomarker in Kidney Renal Clear Cell Carcinoma
    Yange Wang, Chenyang Li, Xinlei Qi, Yafei Yao, Lu Zhang, Guosen Zhang, Longxiang Xie, Qiang Wang, Wan Zhu, Xiangqian Guo
    International Journal of Molecular Sciences.2022; 23(15): 8799.     CrossRef
  • Differential modulation of lung aquaporins among other pathophysiological markers in acute (Cl2 gas) and chronic (carbon nanoparticles, cigarette smoke) respiratory toxicity mouse models
    Sukanta S. Bhattacharya, Brijesh Yadav, Ekta Yadav, Ariel Hus, Niket Yadav, Perminder Kaur, Lauren Rosen, Roman Jandarov, Jagjit S. Yadav
    Frontiers in Physiology.2022;[Epub]     CrossRef
  • Aquaporin water channels as regulators of cell-cell adhesion proteins
    Sarannya Edamana, Frédéric H. Login, Soichiro Yamada, Tae-Hwan Kwon, Lene N. Nejsum
    American Journal of Physiology-Cell Physiology.2021; 320(5): C771.     CrossRef
  • Targeting Aquaporins in Novel Therapies for Male and Female Breast and Reproductive Cancers
    Sidra Khan, Carmela Ricciardelli, Andrea J. Yool
    Cells.2021; 10(2): 215.     CrossRef
  • Targeting ion channels for the treatment of lung cancer
    Liqin Zhang, Shuya Bing, Mo Dong, Xiaoqiu Lu, Yuancheng Xiong
    Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2021; 1876(2): 188629.     CrossRef
  • Comprehensive Analysis of Aquaporin Superfamily in Lung Adenocarcinoma
    Guofu Lin, Luyang Chen, Lanlan Lin, Hai Lin, Zhifeng Guo, Yingxuan Xu, Chanchan Hu, Jinglan Fu, Qinhui Lin, Wenhan Chen, Yiming Zeng, Yuan Xu
    Frontiers in Molecular Biosciences.2021;[Epub]     CrossRef
  • Diagnostic accuracy of urinary aquaporin-1 as a biomarker for renal cell carcinoma
    Abhilash Cheriyan, Arun Jose Nellickal, Nirmal Thampi John, Lakshmanan Jeyaseelan, Santosh Kumar, Antony Devasia, Nitin Kekre
    Indian Journal of Urology.2021; 37(1): 59.     CrossRef
  • Aquaporin 1, 3, and 5 Patterns in Salivary Gland Mucoepidermoid Carcinoma: Expression in Surgical Specimens and an In Vitro Pilot Study
    Mérin Barbara Stamboni, Ágatha Nagli de Mello Gomes, Milena Monteiro de Souza, Katia Klug Oliveira, Claudia Fabiana Joca Arruda, Fernanda de Paula, Barbara Beltrame Bettim, Márcia Martins Marques, Luiz Paulo Kowalski, Clóvis Antônio Lopes Pinto, Victor El
    International Journal of Molecular Sciences.2020; 21(4): 1287.     CrossRef
  • Combined Systematic Review and Transcriptomic Analyses of Mammalian Aquaporin Classes 1 to 10 as Biomarkers and Prognostic Indicators in Diverse Cancers
    Pak Hin Chow, Joanne Bowen, Andrea J Yool
    Cancers.2020; 12(7): 1911.     CrossRef
  • Aquaporins in lung health and disease: Emerging roles, regulation, and clinical implications
    Ekta Yadav, Niket Yadav, Ariel Hus, Jagjit S. Yadav
    Respiratory Medicine.2020; 174: 106193.     CrossRef
  • Dissecting gene‐environment interactions: A penalized robust approach accounting for hierarchical structures
    Cen Wu, Yu Jiang, Jie Ren, Yuehua Cui, Shuangge Ma
    Statistics in Medicine.2018; 37(3): 437.     CrossRef
  • Immunohistochemical Expression of Aquaporin-1 in Fluoro-Edenite-Induced Malignant Mesothelioma: A Preliminary Report
    Giuseppe Angelico, Rosario Caltabiano, Carla Loreto, Antonio Ieni, Giovanni Tuccari, Caterina Ledda, Venerando Rapisarda
    International Journal of Molecular Sciences.2018; 19(3): 685.     CrossRef
  • Mechanisms of Aquaporin-Facilitated Cancer Invasion and Metastasis
    Michael L. De Ieso, Andrea J. Yool
    Frontiers in Chemistry.2018;[Epub]     CrossRef
  • Aquaporin 1 suppresses apoptosis and affects prognosis in esophageal squamous cell carcinoma
    Yuzo Yamazato, Atsushi Shiozaki, Daisuke Ichikawa, Toshiyuki Kosuga, Katsutoshi Shoda, Tomohiro Arita, Hirotaka Konishi, Shuhei Komatsu, Takeshi Kubota, Hitoshi Fujiwara, Kazuma Okamoto, Mitsuo Kishimoto, Eiichi Konishi, Yoshinori Marunaka, Eigo Otsuji
    Oncotarget.2018; 9(52): 29957.     CrossRef
  • Aquaporin 1 expression is associated with response to adjuvant chemotherapy in stage�II and III colorectal cancer
    Hideko Imaizumi, Keiichiro Ishibashi, Seiichi Takenoshita, Hideyuki Ishida
    Oncology Letters.2018;[Epub]     CrossRef
  • Aquaporin 3 facilitates tumor growth in pancreatic cancer by modulating mTOR signaling
    Xunwei Huang, Li Huang, Minhua Shao
    Biochemical and Biophysical Research Communications.2017; 486(4): 1097.     CrossRef
  • Prognostic implication of aquaporin 1 overexpression in resected lung adenocarcinoma†
    Guido Bellezza, Jacopo Vannucci, Fortunato Bianconi, Giulio Metro, Rachele Del Sordo, Marco Andolfi, Ivana Ferri, Paola Siccu, Vienna Ludovini, Francesco Puma, Angelo Sidoni, Lucio Cagini
    Interactive CardioVascular and Thoracic Surgery.2017; 25(6): 856.     CrossRef
Review
Dysembryoplastic Neuroepithelial Tumors
Yeon-Lim Suh
J Pathol Transl Med. 2015;49(6):438-449.   Published online October 23, 2015
DOI: https://doi.org/10.4132/jptm.2015.10.05
  • 13,374 View
  • 277 Download
  • 25 Web of Science
  • 29 Crossref
AbstractAbstract PDF
Dysembryoplastic neuroepithelial tumor (DNT) is a benign glioneuronal neoplasm that most commonly occurs in children and young adults and may present with medically intractable, chronic seizures. Radiologically, this tumor is characterized by a cortical topography and lack of mass effect or perilesional edema. Partial complex seizures are the most common presentation. Three histologic subtypes of DNTs have been described. Histologically, the recognition of a unique, specific glioneuronal element in brain tumor samples from patients with medically intractable, chronic epilepsy serves as a diagnostic feature for complex or simple DNT types. However, nonspecific DNT has diagnostic difficulty because its histology is indistinguishable from conventional gliomas and because a specific glioneuronal element and/or multinodularity are absent. This review will focus on the clinical, radiographic, histopathological, and immunohistochemical features as well as the molecular genetics of all three variants of DNTs. The histological and cytological differential diagnoses for this lesion, especially the nonspecific variant, will be discussed.

Citations

Citations to this article as recorded by  
  • Pediatric Neuroglial Tumors: A Review of Ependymoma and Dysembryoplastic Neuroepithelial Tumor
    Melissa Arfuso, Sandeepkumar Kuril, Harshal Shah, Derek Hanson
    Pediatric Neurology.2024; 156: 139.     CrossRef
  • From bedside to bench: New insights in epilepsy‐associated tumors based on recent classification updates and animal models on brain tumor networks
    Silvia Cases‐Cunillera, Lea L. Friker, Philipp Müller, Albert J. Becker, Gerrit H. Gielen
    Molecular Oncology.2024; 18(12): 2951.     CrossRef
  • Imaging of pediatric glioneuronal and neuronal tumors
    Vivek Pai, Suzanne Laughlin, Birgit Ertl-Wagner
    Child's Nervous System.2024; 40(10): 3007.     CrossRef
  • Dysembryoplastic Neuroepithelial Tumor: A Case Report of A Benign Intracranial Lesion Masquerading as Seizure Disorder
    Garima S Agarwal, Anil K Agrawal, Daksh Singhal, Jayashree Bhawani
    Cureus.2024;[Epub]     CrossRef
  • Super T2-FLAIR mismatch sign: a prognostic imaging biomarker for non-enhancing astrocytoma, IDH-mutant
    Iori Ozono, Shumpei Onishi, Ushio Yonezawa, Akira Taguchi, Novita Ikbar Khairunnisa, Vishwa Jeet Amatya, Fumiyuki Yamasaki, Yukio Takeshima, Nobutaka Horie
    Journal of Neuro-Oncology.2024; 169(3): 571.     CrossRef
  • Genotype-relevant neuroimaging features in low-grade epilepsy-associated tumors
    Keiya Iijima, Hiroyuki Fujii, Fumio Suzuki, Kumiko Murayama, Yu-ichi Goto, Yuko Saito, Terunori Sano, Hiroyoshi Suzuki, Hajime Miyata, Yukio Kimura, Takuma Nakashima, Hiromichi Suzuki, Masaki Iwasaki, Noriko Sato
    Frontiers in Neurology.2024;[Epub]     CrossRef
  • Extra-temporal pediatric low-grade gliomas and epilepsy
    José Hinojosa, Victoria Becerra, Santiago Candela-Cantó, Mariana Alamar, Diego Culebras, Carlos Valencia, Carlos Valera, Jordi Rumiá, Jordi Muchart, Javier Aparicio
    Child's Nervous System.2024; 40(10): 3309.     CrossRef
  • Atypical Presentation of Dysembryoplastic Neuroepithelial Tumor
    Varis S. Khalilov, Aleksey N. Kislyakov, Natalia A. Medvedeva, Natalia S. Serova
    Annals of Clinical and Experimental Neurology.2024; 18(3): 109.     CrossRef
  • Unusual low-grade neuroepithelial tumour in a child
    Leia Salongo, Ali Nael, Pournima Navalkele, John Ross Crawford
    BMJ Case Reports.2024; 17(10): e262692.     CrossRef
  • Glioneuronal and Neuronal Tumors: Who? When? Where? An Update Based on the 2021 World Health Organization Classification
    A.S. Ayres, G.A. Bandeira, S.F. Ferraciolli, J.T. Takahashi, R.A. Moreno, L.F. de Souza Godoy, Y.R. Casal, L.G.C.A. de Lima, F.P. Frasseto, L.T. Lucato
    Neurographics.2023; 13(1): 1.     CrossRef
  • Biological functions of the Olig gene family in brain cancer and therapeutic targeting
    Jenny I. Szu, Igor F. Tsigelny, Alexander Wojcinski, Santosh Kesari
    Frontiers in Neuroscience.2023;[Epub]     CrossRef
  • Aspekte der Bildgebung des Hippokampus
    Isabela S. Alves, Artur M. N. Coutinho, Ana Vieira, Bruno P. Rocha, Ula L. Passos, Vinicius T. Gonçalves, Paulo D. S. Silva, Malia X. Zhan, Paula C. Pinho, Daniel S. Delgado, Marcos F. L. Docema, Hae W. Lee, Bruno A. Policeni, Claudia C. Leite, Maria G. M
    Neuroradiologie Scan.2023; 13(03): 197.     CrossRef
  • T2-FLAIR Mismatch Sign in Pediatric Low-Grade Glioma
    M.W. Wagner, L. Nobre, K. Namdar, F. Khalvati, U. Tabori, C. Hawkins, B.B. Ertl-Wagner
    American Journal of Neuroradiology.2023; 44(7): 841.     CrossRef
  • Clinicopathological features of dysembryoplastic neuroepithelial tumor: a case series
    Shabina Rahim, Nasir Ud Din, Jamshid Abdul-Ghafar, Qurratulain Chundriger, Poonum Khan, Zubair Ahmad
    Journal of Medical Case Reports.2023;[Epub]     CrossRef
  • Imaging Aspects of the Hippocampus
    Isabela S. Alves, Artur M. N. Coutinho, Ana P. F. Vieira, Bruno P. Rocha, Ula L. Passos, Vinicius T. Gonçalves, Paulo D. S. Silva, Malia X. Zhan, Paula C. Pinho, Daniel S. Delgado, Marcos F. L. Docema, Hae W. Lee, Bruno A. Policeni, Claudia C. Leite, Mari
    RadioGraphics.2022; 42(3): 822.     CrossRef
  • Dysembryoplastic neuroepithelial tumors: A single-institutional series with special reference to glutamine synthetase expression
    Chiara Caporalini, Mirko Scagnet, Selene Moscardi, Gioia Di Stefano, Gianna Baroni, Flavio Giordano, Federico Mussa, Carmen Barba, Iacopo Sardi, Lorenzo Genitori, Anna Maria Buccoliero
    Annals of Diagnostic Pathology.2021; 54: 151774.     CrossRef
  • Unusual case of occipital lobe dysembryoplastic neuroepithelial tumour withGNAi1-BRAFfusion
    Jennifer H Yang, Denise M Malicki, Michael L Levy, John Ross Crawford
    BMJ Case Reports.2021; 14(1): e241440.     CrossRef
  • Malformations of Cortical Development, Cognitive Involvementand Epilepsy: A Single Institution Experience in 19 Young Patients
    Valeria Venti, Maria Chiara Consentino, Pierluigi Smilari, Filippo Greco, Claudia Francesca Oliva, Agata Fiumara, Raffaele Falsaperla, Martino Ruggieri, Piero Pavone
    Children.2021; 8(8): 637.     CrossRef
  • A Case of Dysembryoplastic Neuroepithelial Tumor in an Adolescent Male
    Marcel Yibirin, Diana De Oliveira, Isabella Suarez, Gabriela Lombardo, Carlos Perez
    Cureus.2021;[Epub]     CrossRef
  • Clinical and histopathological profile of dysembryoplastic neuroepithelial tumor
    Pooja Gupta, Fouzia Siraj, Akanksha Malik, K. B. Shankar
    Journal of Cancer Research and Therapeutics.2021; 17(4): 912.     CrossRef
  • Neuroradiological and pathomorphological features of epilepsy associated brain tumors
    V. S. Khalilov, A. A. Kholin, A. N. Kisyakov, N. A. Medvedeva, B. R. Bakaeva
    Diagnostic radiology and radiotherapy.2021; 12(2): 7.     CrossRef
  • Evaluación prequirúrgica mediante resonancia magnética funcional en pacientes con tumores neuroepiteliales disembrioplásicos: una serie de casos
    Natalia García-Casares, Francisco Alfaro-Rubio, José Ramón Ramos-Rodríguez, Álvaro Ocaña-Ledesma, Bernarda Márquez-Márquez, Victoria E. Fernández-Sánchez, Guillermo Ibáñez-Botella, Miguel Ángel Arráez-Sánchez, Pedro J. Serrano-Castro
    Neurocirugía.2020; 31(4): 158.     CrossRef
  • Features of the neuroradiological picture of ganglioglioma on the example of 20 clinical cases
    V.S. Khalilov, A.A. Kholin, Kh.Sh. Gazdieva, A.N. Kislyakov, N.N. Zavadenko
    Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova.2020; 120(11): 90.     CrossRef
  • Malignant Glial Neuronal Tumors After West Nile Virus Neuroinvasive Disease: A Coincidence or a Clue?
    Akanksha Sharma, Marie F. Grill, Scott Spritzer, A. Arturo Leis, Mark Anderson, Parminder Vig, Alyx B. Porter
    The Neurohospitalist.2019; 9(3): 160.     CrossRef
  • Particularities in differential diagnostics of epileptogenic brain malformations on the low-field MRI-device
    V. S. Khalilov, A. A. Kholin, B. R. Bakaeva, M. Yu. Bobylova, Kh. Sh. Gazdieva
    Russian Journal of Child Neurology.2019; 13(4): 23.     CrossRef
  • Dysembryoplastic Neuroepithelial Tumors: What You Need to Know
    Sabino Luzzi, Angela Elia, Mattia Del Maestro, Samer K. Elbabaa, Sergio Carnevale, Francesco Guerrini, Massimo Caulo, Patrizia Morbini, Renato Galzio
    World Neurosurgery.2019; 127: 255.     CrossRef
  • The miR‐139‐5p regulates proliferation of supratentorial paediatric low‐grade gliomas by targeting the PI3K/AKT/mTORC1 signalling
    G. Catanzaro, Z. M. Besharat, E. Miele, M. Chiacchiarini, A. Po, A. Carai, C. E. Marras, M. Antonelli, M. Badiali, A. Raso, S. Mascelli, D. Schrimpf, D. Stichel, M. Tartaglia, D. Capper, A. von Deimling, F. Giangaspero, A. Mastronuzzi, F. Locatelli, E. Fe
    Neuropathology and Applied Neurobiology.2018; 44(7): 687.     CrossRef
  • Dysembryoplastic Neuroectodermal Tumor: An Analysis from the Surveillance, Epidemiology, and End Results Program, 2004–2013
    Ha Son Nguyen, Ninh Doan, Michael Gelsomino, Saman Shabani
    World Neurosurgery.2017; 103: 380.     CrossRef
  • Common Histologically Benign Tumors of the Brain
    Roy E. Strowd, Jaishri O. Blakeley
    CONTINUUM: Lifelong Learning in Neurology.2017; 23(6): 1680.     CrossRef
Original Articles
The Role of TWIST in Ovarian Epithelial Cancers
Kyungbin Kim, Eun Young Park, Man Soo Yoon, Dong Soo Suh, Ki Hyung Kim, Jeong Hee Lee, Dong Hoon Shin, Jee Yeon Kim, Mee Young Sol, Kyung Un Choi
Korean J Pathol. 2014;48(4):283-291.   Published online August 26, 2014
DOI: https://doi.org/10.4132/KoreanJPathol.2014.48.4.283
  • 8,240 View
  • 42 Download
  • 12 Crossref
AbstractAbstract PDF
Background

Epithelial-mesenchymal transition (EMT) is associated with tumor hypoxia. EMT is regulated, in part, by the action of TWIST, which inhibits of E-cadherin expression and may interfere with the p53 tumor-suppressor pathway.

Methods

We examined the expression of TWIST, E-cadherin, hypoxia-inducible factor 1α (HIF1α), and p53 by immunohistochemistry in 123 cases of ovarian epithelial cancers (OEC) to evaluate the role of TWIST in OEC. We assessed the association between protein expression and clinicopathologic parameters.

Results

The expression of TWIST, E-cadherin, HIF1α, and p53 proteins was found in 28.5%, 51.2%, 35.0%, and 29.3% of cases, respectively. TWIST expression was associated with higher histologic grade and unfavorable survival. TWIST expression was correlated with HIF1α expression and reduced E-cadherin expression. The altered HIF1α/TWIST/E-cadherin pathway was associated with lower overall survival (OS), while the co-expression of TWIST and p53 was correlated with lower progression-free survival. In the multivariate analyses, TWIST expression was an independent prognostic factor for OS.

Conclusions

Our data imply that TWIST expression could be a useful predictor of unfavorable prognosis for OEC. TWIST may affect the p53 tumor-suppressor pathway. Moreover, hypoxia-mediated EMT, which involves the HIF1α/TWIST/E-cadherin pathway may play an important role in the progression of OEC.

Citations

Citations to this article as recorded by  
  • The Mechanism and Dynamic Regulation of Epithelial to Mesenchymal Transition in Ovarian Cancer
    Pande Kadek Aditya Prayudi, I Gde Sastra Winata, I Nyoman Bayu Mahendra, I Nyoman Gede Budiana, Kade Yudi Saspriyana, Ketut Suwiyoga
    Clinical and Experimental Obstetrics & Gynecology.2023;[Epub]     CrossRef
  • E-Cadherin Expression in Relation to Clinicopathological Parameters and Survival of Patients with Epithelial Ovarian Cancer
    Michal Kielbik, Izabela Szulc-Kielbik, Magdalena Klink
    International Journal of Molecular Sciences.2022; 23(22): 14383.     CrossRef
  • Oxygen sensing, mitochondrial biology and experimental therapeutics for pulmonary hypertension and cancer
    Danchen Wu, Asish Dasgupta, Austin D. Read, Rachel E.T. Bentley, Mehras Motamed, Kuang-Hueih Chen, Ruaa Al-Qazazi, Jeffrey D. Mewburn, Kimberly J. Dunham-Snary, Elahe Alizadeh, Lian Tian, Stephen L. Archer
    Free Radical Biology and Medicine.2021; 170: 150.     CrossRef
  • Hypoxia-Induced Epithelial-Mesenchymal Transition in Cancers: HIF-1α and Beyond
    Shing Yau Tam, Vincent W. C. Wu, Helen K. W. Law
    Frontiers in Oncology.2020;[Epub]     CrossRef
  • Expression of selected epithelial–mesenchymal transition transcription factors in serous borderline ovarian tumors and type I ovarian cancers
    Pawel Sadlecki, Jakub Jóźwicki, Paulina Antosik, Marek Grabiec
    Tumor Biology.2018; 40(6): 101042831878480.     CrossRef
  • Expression and prognostic significance of epithelial-mesenchymal transition-related markers and phenotype in serous ovarian cancer
    In Hye Song, Kyu-Rae Kim, Sehun Lim, Seok-Hyung Kim, Chang Ohk Sung
    Pathology - Research and Practice.2018; 214(10): 1564.     CrossRef
  • Transcription factors controlling E-cadherin down-regulation in ovarian cancer
    Holly Russell, Md Zahidul Islam Pranjol
    Bioscience Horizons: The International Journal of Student Research.2018;[Epub]     CrossRef
  • Immunohistochemical expression of TWIST in oral squamous cell carcinoma and its correlation with clinicopathologic factors
    Maryam Seyedmajidi, Safoura Seifi, Dariush Moslemi, Seyyedeh-Fatemeh Mozaffari, Hemmat Gholinia, Zahra Zolfaghari
    Journal of Cancer Research and Therapeutics.2018; 14(5): 964.     CrossRef
  • Activation of TWIST1 by COL11A1 promotes chemoresistance and inhibits apoptosis in ovarian cancer cells by modulating NF‐κB‐mediated IKKβ expression
    Yi‐Hui Wu, Yu‐Fang Huang, Tzu‐Hao Chang, Cheng‐Yang Chou
    International Journal of Cancer.2017; 141(11): 2305.     CrossRef
  • MicroRNA-219-5p inhibits the proliferation, migration, and invasion of epithelial ovarian cancer cells by targeting the Twist/Wnt/β-catenin signaling pathway
    Chunyan Wei, Xi Zhang, Sai He, Bianli Liu, Hongfang Han, Xuejun Sun
    Gene.2017; 637: 25.     CrossRef
  • Inhibition of proliferation and invasion of hepatocellular carcinoma cells by lncRNA-ASLNC02525 silencing and the mechanism
    Zi Chen, Dongwen Xu, Tao Zhang
    International Journal of Oncology.2017; 51(3): 851.     CrossRef
  • Is overexpression of TWIST, a transcriptional factor, a prognostic biomarker of head and neck carcinoma? Evidence from fifteen studies
    Xianlu Zhuo, Huanli Luo, Aoshuang Chang, Dairong Li, Houyu Zhao, Qi Zhou
    Scientific Reports.2015;[Epub]     CrossRef
Alteration of the E-Cadherin/β-Catenin Complex Is an Independent Poor Prognostic Factor in Lung Adenocarcinoma
Hyojin Kim, Seol Bong Yoo, Pingli Sun, Yan Jin, Sanghoon Jheon, Choon Taek Lee, Jin-Haeng Chung
Korean J Pathol. 2013;47(1):44-51.   Published online February 25, 2013
DOI: https://doi.org/10.4132/KoreanJPathol.2013.47.1.44
  • 10,937 View
  • 61 Download
  • 35 Crossref
AbstractAbstract PDF
Background

Epithelial-mesenchymal transition (EMT) is an important step in the invasion and progression of cancer and in the development of chemoresistance by cancer cells.

Methods

To address the clinical significance of the EMT pathway in lung adenocarcinoma and the association of the pathway with histological subtype, we examined 193 surgically resected lung adenocarcinoma samples for the expression of representative EMT-related proteins (E-cadherin, β-catenin, and vimentin) by immunohistochemistry. Histological subtypes were classified according to the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. The results for EMT-related protein expression were analyzed for correlation with clinicopathological features and with survival.

Results

The loss of E-cadherin expression and aberrant β-catenin expression were significantly associated with larger tumor size, pleural invasion, lymphatic/vascular invasion, and advanced pathological stage (p<0.05). The alteration of the E-cadherin/β-catenin complex was least frequently observed in the lepidic-predominant group, but these associations were not statistically significant. In the multivariate analysis, altered E-cadherin/β-catenin complex expression was found to be an independent poor prognostic factor (p=0.017; hazard ratio, 1.926; 95% confidence interval, 1.119 to 3.314).

Conclusions

The alteration of the expression of the E-cadherin/β-catenin complex was associated with aggressive tumor behavior in lung adenocarcinoma.

Citations

Citations to this article as recorded by  
  • Prognostic significance of stem cell-related marker expression and its correlation with histologic subtypes in lung adenocarcinoma
    Eunhyang Park, Soo Young Park, Ping-Li Sun, Yan Jin, Ji Eun Kim, Sanghoon Jheon, Kwhanmien Kim, Choon Taek Lee, Hyojin Kim, Jin-Haeng Chung
    Oncotarget.2106; 7(27): 42502.     CrossRef
  • Epigenetic Alterations of DNA Methylation and miRNA Contribution to Lung Adenocarcinoma
    Wenhan Cai, Miao Jing, Jiaxin Wen, Hua Guo, Zhiqiang Xue
    Frontiers in Genetics.2022;[Epub]     CrossRef
  • Clinicopathological significance and prognostic value of E-cadherin expression in non-small cell lung cancer
    Dong Chao, Gawei Hu, Qingxin Li
    Medicine.2021; 100(7): e24748.     CrossRef
  • Aberrant Expression of β-Catenin Correlates with Infiltrating Immune Cells and Prognosis in NSCLC
    Hongmei Zheng, Yue Ning, Yang Yang, Yuting Zhan, Haihua Wang, Qiuyuan Wen, Jinwu Peng, Songqing Fan
    Pathology and Oncology Research.2021;[Epub]     CrossRef
  • Prognostic Significance of Wnt1, Wnt2, E-Cadherin, and β-catenin Expression in Operable Non-small Cell Lung Cancer
    Anna Wrona, Aleksandra Sejda, Rafał Dziadziuszko, Jacek Jassem
    Journal of Histochemistry & Cytochemistry.2021; 69(11): 711.     CrossRef
  • Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases
    Ye Yu, Xuemei Tian
    Medicine.2020; 99(19): e20183.     CrossRef
  • The roles of TG-interacting factor in cadmium exposure-promoted invasion and migration of lung cancer cells
    Yadong Wang, Li Shi, Jiangmin Li, Haiyu Wang, Haiyan Yang
    Toxicology in Vitro.2019; 61: 104630.     CrossRef
  • Pizotifen inhibits the proliferation and invasion of gastric cancer cells
    Ying Jiang, Wei Wang, Xi Wu, Jihua Shi
    Experimental and Therapeutic Medicine.2019;[Epub]     CrossRef
  • SNAI2 and TWIST1 in lymph node progression in early stages of NSCLC patients
    Camille Emprou, Pauline Le Van Quyen, Jérémie Jégu, Nathalie Prim, Noëlle Weingertner, Eric Guérin, Erwan Pencreach, Michèle Legrain, Anne‐Claire Voegeli, Charlotte Leduc, Bertrand Mennecier, Pierre‐Emmanuel Falcoz, Anne Olland, Nicolas Santelmo, Elisabet
    Cancer Medicine.2018; 7(7): 3278.     CrossRef
  • E-Cadherin Loss Accelerates Tumor Progression and Metastasis in a Mouse Model of Lung Adenocarcinoma
    Kerstin W. Sinkevicius, Kelly J. Bellaria, Juliana Barrios, Patrizia Pessina, Manav Gupta, Christine Fillmore Brainson, Roderick T. Bronson, Carla F. Kim
    American Journal of Respiratory Cell and Molecular Biology.2018; 59(2): 237.     CrossRef
  • Downregulation of peroxiredoxin II suppresses the proliferation and metastasis of gastric cancer cells
    Linjun Niu, Ang Liu, Wei Xu, Liang Yang, Wugang Zhu, Yuming Gu
    Oncology Letters.2018;[Epub]     CrossRef
  • Implications of NOVA1 suppression within the microenvironment of gastric cancer: association with immune cell dysregulation
    Eun Kyung Kim, Sun Och Yoon, Woon Yong Jung, Hyunjoo Lee, Youngran Kang, You-Jin Jang, Soon Won Hong, Seung Ho Choi, Woo Ick Yang
    Gastric Cancer.2017; 20(3): 438.     CrossRef
  • High FDG uptake on PET is associated with negative cell-to-cell adhesion molecule E-cadherin expression in lung adenocarcinoma
    Kotaro Higashi, Yoshimichi Ueda, Miyako Shimasaki, Yasuhito Ishigaki, Yuka Nakamura, Manabu Oguchi, Tsutomu Takegami, Naoto Watanabe
    Annals of Nuclear Medicine.2017; 31(8): 590.     CrossRef
  • MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR, KRAS, and ALK status
    Hyojin Kim, Jeong Mi Yang, Yan Jin, Sanghoon Jheon, Kwhanmien Kim, Choon Taek Lee, Jin-Haeng Chung, Jin Ho Paik
    Oncotarget.2017; 8(5): 8484.     CrossRef
  • A meta-analysis of abnormal β-catenin immunohistochemical expression as a prognostic factor in lung cancer: location is more important
    Y. Yang, J. Shen, Jiaxi He, Jianxing He, G. Jiang
    Clinical and Translational Oncology.2016; 18(7): 685.     CrossRef
  • Aquaporin 1 Is an Independent Marker of Poor Prognosis in Lung Adenocarcinoma
    Sumi Yun, Ping-Li Sun, Yan Jin, Hyojin Kim, Eunhyang Park, Soo Young Park, Kyuho Lee, Kyoungyul Lee, Jin-Haeng Chung
    Journal of Pathology and Translational Medicine.2016; 50(4): 251.     CrossRef
  • Prognostic Values of Vimentin Expression and Its Clinicopathological Significance in Non-Small Cell Lung Cancer: A Meta-Analysis of Observational Studies with 4118 Cases
    Zhihua Ye, Xin Zhang, Yihuan Luo, Shikang Li, Lanshan Huang, Zuyun Li, Ping Li, Gang Chen, Aamir Ahmad
    PLOS ONE.2016; 11(9): e0163162.     CrossRef
  • Myoferlin expression in non-small cell lung cancer: Prognostic role and correlation with VEGFR-2 expression
    DAE HYUN SONG, GYUNG HYUCK KO, JEONG HEE LEE, JONG SIL LEE, GYEONG-WON LEE, HYEON CHEOL KIM, JUNG WOOK YANG, ROK WON HEO, GU SEOB ROH, SUN-YOUNG HAN, DONG CHUL KIM
    Oncology Letters.2016; 11(2): 998.     CrossRef
  • Short hairpin RNA silencing of TGF-βRII and FZD-7 synergistically suppresses proliferation and metastasis of hepatocellular carcinoma cells
    CONG CHEN, YUYANG XUE, DEJUN ZHANG, WEI XU, HAO XU, HONG YAO, DONGSHENG PEI, YUMING GU
    Oncology Letters.2016; 11(3): 2039.     CrossRef
  • NOVA1 inhibition by miR-146b-5p in the remnant tissue microenvironment defines occult residual disease after gastric cancer removal
    Sun Och Yoon, Eun Kyung Kim, Mira Lee, Woon Yong Jung, Hyunjoo Lee, Youngran Kang, You-Jin Jang, Soon Won Hong, Seung Ho Choi, Woo Ick Yang
    Oncotarget.2016; 7(3): 2475.     CrossRef
  • Immunohistochemical demonstration of alteration of β-catenin during tumor metastasis by different mechanisms according to histology in lung cancer
    XIANHUA XU, JI EUN KIM, PING-LI SUN, SEOL BONG YOO, HYOJIN KIM, YAN JIN, JIN-HAENG CHUNG
    Experimental and Therapeutic Medicine.2015; 9(2): 311.     CrossRef
  • FRK Inhibits Migration and Invasion of Human Glioma Cells by Promoting N-cadherin/β-catenin Complex Formation
    Qiong Shi, Xu Song, Jun Wang, Jia Gu, Weijian Zhang, Jinxia Hu, Xiuping Zhou, Rutong Yu
    Journal of Molecular Neuroscience.2015; 55(1): 32.     CrossRef
  • Dissociation of E-cadherin/β-catenin complex by MG132 and bortezomib enhances CDDP induced cell death in oral cancer SCC-25 cells
    Lanhai Lü, Xiqiang Liu, Cheng Wang, Fengchun Hu, Jianning Wang, Hongzhang Huang
    Toxicology in Vitro.2015; 29(8): 1965.     CrossRef
  • Epigallocatechin-3-gallate inhibits nicotine-induced migration and invasion by the suppression of angiogenesis and epithelial-mesenchymal transition in non-small cell lung cancer cells
    JINGLI SHI, FEI LIU, WENZHANG ZHANG, XIN LIU, BIHUA LIN, XUDONG TANG
    Oncology Reports.2015; 33(6): 2972.     CrossRef
  • Clinicopathologic and prognostic significance of c-MYC copy number gain in lung adenocarcinomas
    A N Seo, J M Yang, H Kim, S Jheon, K Kim, C T Lee, Y Jin, S Yun, J-H Chung, J H Paik
    British Journal of Cancer.2014; 110(11): 2688.     CrossRef
  • The Clinicopathological Significance of Epithelial Mesenchymal Transition Associated Protein Expression in Head and Neck Squamous Cell Carcinoma
    Kyu Ho Kim, Lucia Kim, Suk Jin Choi, Jee Young Han, Joon Mee Kim, Young Chae Chu, Young-Mo Kim, In Suh Park, Joo Han Lim
    Korean Journal of Pathology.2014; 48(4): 263.     CrossRef
  • Adenoid dysplasia of the oral mucosa
    Belinda Bunn, Keith Hunter, Syed Ali Khurram, W.F.P. van Heerden
    Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.2014; 118(5): 586.     CrossRef
  • FGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer
    An Na Seo, Yan Jin, Hee Jin Lee, Ping-Li Sun, Hyojin Kim, Sanghoon Jheon, Kwhanmien Kim, Choon-Taek Lee, Jin-Haeng Chung
    Virchows Archiv.2014; 465(5): 547.     CrossRef
  • FNC, a Novel Nucleoside Analogue, Blocks Invasion of Aggressive Non-Hodgkin Lymphoma Cell Lines Via Inhibition of the Wnt/β-Catenin Signaling Pathway
    Yan Zhang, Chen-Ping Wang, Xi-Xi Ding, Ning Wang, Fang Ma, Jin-Hua Jiang, Qing-Duan Wang, Jun-Biao Chang
    Asian Pacific Journal of Cancer Prevention.2014; 15(16): 6829.     CrossRef
  • β-Catenin overexpression is associated with gefitinib resistance in non-small cell lung cancer cells
    Xia Fang, Pan Gu, Caicun Zhou, Aibin Liang, Shenxiang Ren, Fang Liu, Yu Zeng, Yunjin Wu, Yinmin Zhao, Binbin Huang, Zongmei Zhang, Xianghua Yi
    Pulmonary Pharmacology & Therapeutics.2014; 28(1): 41.     CrossRef
  • Tumor‐size‐based morphological features of metastatic lymph node tumors from primary lung adenocarcinoma
    Eiji Yamada, Genichiro Ishii, Nao Aramaki, Keiju Aokage, Tomoyuki Hishida, Junji Yoshida, Motohiro Kojima, Kanji Nagai, Atsushi Ochiai
    Pathology International.2014; 64(12): 591.     CrossRef
  • Prognostic and Clinicopathological Significance of Downregulated E-Cadherin Expression in Patients with Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis
    Yan-Long Yang, Ming-Wu Chen, Lei Xian, Alfons Navarro
    PLoS ONE.2014; 9(6): e99763.     CrossRef
  • Hepatic Stellate Cells Secreted Hepatocyte Growth Factor Contributes to the Chemoresistance of Hepatocellular Carcinoma
    Guofeng Yu, Yingying Jing, Xingrui Kou, Fei Ye, Lu Gao, Qingmin Fan, Yang Yang, Qiudong Zhao, Rong Li, Mengchao Wu, Lixin Wei, Xin-Yuan Guan
    PLoS ONE.2013; 8(9): e73312.     CrossRef
  • A Comprehensive Comparative Analysis of the Histomorphological Features of ALK-Rearranged Lung Adenocarcinoma Based on Driver Oncogene Mutations: Frequent Expression of Epithelial-Mesenchymal Transition Markers than Other Genotype
    Hyojin Kim, Se Jin Jang, Doo Hyun Chung, Seol Bong Yoo, Pingli Sun, Yan Jin, Kyung Han Nam, Jin-Ho Paik, Jin-Haeng Chung, Alfredo Fusco
    PLoS ONE.2013; 8(10): e76999.     CrossRef
  • Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes
    Roberto Gomez-Casal, Chitralekha Bhattacharya, Nandita Ganesh, Lisa Bailey, Per Basse, Michael Gibson, Michael Epperly, Vera Levina
    Molecular Cancer.2013;[Epub]     CrossRef
Prognostic Relevance of the Expression of CA IX, GLUT-1, and VEGF in Ovarian Epithelial Cancers
Kyungbin Kim, Won Young Park, Jee Yeon Kim, Mee Young Sol, Dong Hun Shin, Do Youn Park, Chang Hun Lee, Jeong Hee Lee, Kyung Un Choi
Korean J Pathol. 2012;46(6):532-540.   Published online December 26, 2012
DOI: https://doi.org/10.4132/KoreanJPathol.2012.46.6.532
  • 9,200 View
  • 42 Download
  • 13 Crossref
AbstractAbstract PDF
Background

Tumor hypoxia is associated with malignant progression and treatment resistance. Hypoxia-related factors, such as carbonic anhydrase IX (CA IX), glucose transporter-1 (GLUT-1), and vascular endothelial growth factor (VEGF) permit tumor cell adaptation to hypoxia. We attempted to elucidate the correlation of these markers with variable clinicopathological factors and overall prognosis.

Methods

Immunohistochemistry for CA IX, GLUT-1, and VEGF was performed on formalin-fixed, paraffin-embedded tissues from 125 cases of ovarian epithelial cancer (OEC).

Results

CA IX expression was significantly associated with an endometrioid and mucinous histology, nuclear grade, tumor necrosis, and mitosis. GLUT-1 expression was associated with tumor necrosis and mitosis. VEGF expression was correlated only with disease recurrence. Expression of each marker was not significant in terms of overall survival in OECs; however, there was a significant correlation between poor overall survival rate and high coexpression of these markers.

Conclusions

The present study suggests that it is questionable whether CA IX, GLUT-1, or VEGF can be used alone as independent prognostic factors in OECs. Using at least two markers helps to predict patient outcomes in total OECs. Moreover, the inhibition of two target gene combinations might prove to be a novel anticancer therapy.

Citations

Citations to this article as recorded by  
  • Effect of Ultrasound Therapy at the ST11 on Sympathetic Nervous System Change: A Prospective Randomized Controlled Study
    Shinwoo Kang, Dongho Keum
    Journal of Korean Medicine Rehabilitation.2023; 33(4): 167.     CrossRef
  • A systematic review verified by bioinformatic analysis based on TCGA reveals week prognosis power of CAIX in renal cancer
    Zikuan Zhang, Bo Wu, Yuan Shao, Yongquan Chen, Dongwen Wang, Lucia Magnelli
    PLOS ONE.2022; 17(12): e0278556.     CrossRef
  • Effect of Acupuncture at the Field of the Auricular Branch of the Vagus Nerve on Autonomic Nervous System Change
    Sunjoo An, Dongho Keum
    Journal of Korean Medicine Rehabilitation.2021; 31(2): 81.     CrossRef
  • Responses of Autonomic Nervous System and Gastrointestinal Function to Acupuncture at Abdominal Anterior Cutaneous Nerve : A Pilot Study
    Seohyun Park, Hojun Kim, Dongho Keum
    Journal of Korean Medicine.2019; 40(1): 99.     CrossRef
  • Omega-3 polyunsaturated fatty acid docosahexaenoic acid and its role in exhaustive-exercise-induced changes in female rat ovulatory cycle
    Abeer F. Mostafa, Shereen M. Samir, R.M. Nagib
    Canadian Journal of Physiology and Pharmacology.2018; 96(4): 395.     CrossRef
  • Clear cell carcinomas of the ovary and kidney: clarity through genomics
    Jennifer X Ji, Yi Kan Wang, Dawn R Cochrane, David G Huntsman
    The Journal of Pathology.2018; 244(5): 550.     CrossRef
  • Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis
    Simon J. A. van Kuijk, Ala Yaromina, Ruud Houben, Raymon Niemans, Philippe Lambin, Ludwig J. Dubois
    Frontiers in Oncology.2016;[Epub]     CrossRef
  • Review of Research Topics on Abdominal Examination
    Jihye Kim, Jeong Hwan Park, Keun Ho Kim
    Journal of Korean Medicine.2016; 37(3): 1.     CrossRef
  • Expression of hypoxic markers and their prognostic significance in soft tissue sarcoma
    JEUNG IL KIM, KYUNG UN CHOI, IN SOOK LEE, YOUNG JIN CHOI, WON TACK KIM, DONG HOON SHIN, KYUNGBIN KIM, JEONG HEE LEE, JEE YEON KIM, MEE YOUNG SOL
    Oncology Letters.2015; 9(4): 1699.     CrossRef
  • Evaluation of a Hypoxia Regulated Gene Panel in Ovarian Cancer
    Amanda F. Baker, Scott W. Malm, Ritu Pandey, Cindy Laughren, Haiyan Cui, Denise Roe, Setsuko K. Chambers
    Cancer Microenvironment.2015; 8(1): 45.     CrossRef
  • Sulforaphane reduces molecular response to hypoxia in ovarian tumor cells independently of their resistance to chemotherapy
    MICHAL PASTOREK, VERONIKA SIMKO, MARTINA TAKACOVA, MONIKA BARATHOVA, MARIA BARTOSOVA, LUBA HUNAKOVA, OLGA SEDLAKOVA, SONA HUDECOVA, OLGA KRIZANOVA, FRANCK DEQUIEDT, SILVIA PASTOREKOVA, JAN SEDLAK
    International Journal of Oncology.2015; 47(1): 51.     CrossRef
  • Overexpression of Glucose Transporter-1 (GLUT-1) Predicts Poor Prognosis in Epithelial Ovarian Cancer
    Hanbyoul Cho, You Sun Lee, Julie Kim, Joon-Yong Chung, Jae-Hoon Kim
    Cancer Investigation.2013; 31(9): 607.     CrossRef
  • Towards Lipidomics of Low-Abundant Species for Exploring Tumor Heterogeneity Guided by High-Resolution Mass Spectrometry Imaging
    Jonathan Cimino, David Calligaris, Johann Far, Delphine Debois, Silvia Blacher, Nor Sounni, Agnès Noel, Edwin De Pauw
    International Journal of Molecular Sciences.2013; 14(12): 24560.     CrossRef

J Pathol Transl Med : Journal of Pathology and Translational Medicine
TOP